AMANDA EDMOND: Open Payments
NPI 1770767683 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,918 in 68 payments from 8 companies in 2025. Trend: 2023 $257 · 2024 $496 · 2025 $30,918
Speaker / faculty: $13,430Consulting: $9,245Travel & lodging: $6,416Food & beverage: $1,648Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $28,355 |
| Merck Sharp & Dohme LLC | 9 | $1,269 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $814 |
| Janssen Scientific Affairs, LLC | 1 | $144 |
| ABBVIE INC. | 3 | $137 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Caris MPI, Inc. | 2 | $67 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: RYBREVANT, DATROWAY, VENCLEXTA, MI CANCER SEEK, EMRELIS, Cresemba, EPKINLY.
Industry payments across AZ — which companies pay providers there.
